My Diabetes Doc

My Diabetes Doc

Dr. Jonas Leibowitz
Country USA
Language EN
Episodes 1
Latest 13.11.2026

My Diabetes Doc is a podcast that simplifies diabetes care. Hosted by endocrinologist Dr. Jonas Leibowitz, it offers expert insights, practical tips, and the latest advances in diabetes treatment, nutrition, weight management, and metabolic health. The show provides trusted, evidence-based guidance for people living with diabetes, caregivers, and anyone interested in improving their health.

Episodes

  • GLP-1 Medications and Thyroid Cancer: Should You Get Extra Tests or Change Your Treatment?
    GLP-1 Medications and Thyroid Cancer: Should You Get Extra Tests or Change Your Treatment? 13.11.2026 3m
    Could taking a GLP-1 medication increase your risk of thyroid cancer? Should you have additional thyroid blood tests or ultrasounds just because you're taking Ozempic, Wegovy, or another medication in this family?These are important questions, and in this episode, I want to help you understand what the research tells us, what you should actually be doing, and when thyroid concerns need further evaluation.GLP-1 medications have been available for many years, giving researchers opportunities to examine large groups of patients and investigate potential health risks. I'll explain how researchers...
  • GLP-1 Medications and Thyroid Cancer: What You Should Know
    GLP-1 Medications and Thyroid Cancer: What You Should Know 28.10.2026 3m
    Have you heard the thyroid cancer warning associated with GLP-1 medications and wondered what it actually means for you? I understand why this warning can be concerning, especially when you're considering a medication for diabetes or weight management.In this episode of My Diabetes Doc, I explain the specific thyroid concern associated with GLP-1 medications, what researchers observed in animal studies, and why the relevance of those findings to humans remains uncertain.Here's what I cover:What the thyroid warning actually means: I explain the concern involving C-cell tumors observed in rodent...
  • What Happens If You Miss Multiple GLP-1 Doses?
    What Happens If You Miss Multiple GLP-1 Doses? 07.10.2026 3m
    What happens if you miss multiple doses of your GLP-1 medication?In this episode of My Diabetes Doc, Dr. Jonas discusses what can happen when patients go several weeks without their GLP-1 medication and why restarting may require a different approach.Missed doses can happen for many reasons, including travel, medical procedures, surgery, pharmacy or insurance issues, running out of medication, or simply choosing to take a break.Dr. Jonas explains why the length of time you’ve been off the medication, your previous experience with GLP-1 therapy, and how well you tolerate the medication can all...
  • Understanding GLP-1: Incretins, GIP & How GLP-1 Was Discovered
    Understanding GLP-1: Incretins, GIP & How GLP-1 Was Discovered 04.09.2026 4m
    In this episode, I answer three important questions about GLP-1 medications and incretin hormones.First, what is an incretin? I explain how incretin hormones connect food intake with insulin release, blood sugar control, appetite, and the way food moves through the digestive system. I also break down the four major effects associated with GLP-1.Next, I explain what GIP is and why it is becoming increasingly important in diabetes, weight management, and newer medications. GIP is the second most studied incretin hormone after GLP-1, and some medications stimulate both GLP-1 and GIP pathways.Fina...
  • 2 Major Mounjaro Updates Every Diabetes Patient Should Know
    2 Major Mounjaro Updates Every Diabetes Patient Should Know 01.09.2026 2m
    In this episode of the My Diabetes Doc Podcast, Dr. Jonas shares two important updates about Mounjaro (tirzepatide), a GLP-1 and GIP medication used in the treatment of type 2 diabetes.First, Dr. Jonas discusses Mounjaro's new cardiovascular indication for certain patients with type 2 diabetes who are at high risk for cardiovascular disease. He explains recent data comparing Mounjaro with Trulicity, an established GLP-1 medication with cardiovascular benefits, and what the findings may mean for patients at risk of heart attack, stroke, and cardiovascular death.Dr. Jonas also discusses an impor...
  • Medicare GLP-1 Bridge Program: Issues with Qualifying for the Program
    Medicare GLP-1 Bridge Program: Issues with Qualifying for the Program 30.08.2026 5m
    The Medicare GLP-1 Bridge Program was designed to help expand access to certain weight loss medications for eligible Medicare recipients—but qualifying for the program may not always be as straightforward as expected.In this episode of My Diabetes Doc, endocrinologist Dr. Jonas Leibowitz discusses some of the eligibility issues patients may encounter with the Medicare GLP-1 Bridge Program.Dr. Leibowitz explains how the program differs from traditional Medicare Part D coverage and discusses the $50 monthly cost for eligible patients. He also reviews one of the biggest challenges we have seen: p...
  • Zepbound Explained: How It Works, How It’s Dosed & What Patients Should Know
    Zepbound Explained: How It Works, How It’s Dosed & What Patients Should Know 28.08.2026 4m
    How does Zepbound® work, and how is it dosed?In this episode of My Diabetes Doc, Dr. Jonas Leibowitz, an endocrinologist, provides a physician-led overview of Zepbound (tirzepatide), one of the medications included in the Medicare GLP-1 Bridge Program for weight management.In Part 1, Dr. Leibowitz explains how Zepbound works and why it is different from medications that target GLP-1 alone. Zepbound activates two hormone pathways—GLP-1 and GIP—which play important roles in appetite, satiety, blood sugar regulation, and digestion. Dr. Leibowitz explains how these effects can help people feel ful...
  • Wegovy Injection: Summary of what to expect - Medicare GLP-1 Bridge Program
    Wegovy Injection: Summary of what to expect - Medicare GLP-1 Bridge Program 20.08.2026 2m
    In this episode of the My Diabetes Doc Podcast, Dr. Jonas Leibowitz, an endocrinologist with 30 years of experience, provides an overview of the Wegovy injection and what patients should know before beginning treatment through the new Medicare Bridge weight-loss program.Dr. Jonas explains how Wegovy works as a GLP-1 receptor agonist, reviews the available dosing options, and discusses the amount of weight loss patients may expect based on clinical studies. He also reviews common gastrointestinal side effects, including nausea, vomiting, diarrhea, and constipation, along with the importance of...
  • Wegovy Injection: Weight Loss Effect & Side effects
    Wegovy Injection: Weight Loss Effect & Side effects 18.08.2026 4m
    In this episode, I discuss the Wegovy injection, a GLP-1 medication for weight loss, which is part of the new Medicare Bridge program that started on July 1, 2026. In the first part of this episode, I discuss the weight-loss effects you can expect from this medication, and in the second part, I discuss the side effects associated with taking the Wegovy injection.The weight loss data is based on the 2.4 mg and 7.2 mg doses, with expected losses of 16% and 19% body weight, respectively, over a year. Side effects, primarily gastrointestinal, include nausea, vomiting, and dyspepsia. It's crucial t...
  • Introducing the Wegovy Injection & Explaining dosing. Covered under the Medicare GLP-1 Bridge Program
    Introducing the Wegovy Injection & Explaining dosing. Covered under the Medicare GLP-1 Bridge Program 13.08.2026 3m
    Dr. Jonas Leibowitz, an endocrinologist with 30 years of experience, introduces Wegovy, a GLP-1 receptor agonist and one of four medications covered by the new Medicare weight loss program starting July 1, 2026. Wegovy, similar to Ozempic, helps with weight loss by stimulating appetite suppression and regulating blood sugar levels. It comes in six doses, starting from 0.25 mg and increasing up to 7.2 mg, with the option to move between doses every four weeks. Dr. Jonas advises moving slowly through the doses to avoid side effects, especially for older patients, to ensure tolerance and avoid ha...
  • Do You Qualify for Medicare's New GLP-1 Weight Loss Program?
    Do You Qualify for Medicare's New GLP-1 Weight Loss Program? 17.07.2026 5m
    Who qualifies for the new Medicare Bridge GLP-1 Weight Loss Program? In this episode, Dr. Jonas Leibowitz, an endocrinologist with more than 30 years of experience, explains the eligibility requirements for Medicare beneficiaries seeking GLP-1 weight loss medications through the new Bridge Program.Dr. Leibowitz reviews the BMI thresholds, qualifying medical conditions, and the four medications included in the program. He also discusses how conditions such as chronic kidney disease, uncontrolled hypertension, heart failure with preserved ejection fraction (HFpEF), prediabetes, previous heart at...
  • I just found out I have type 2 diabetes, and I have symptoms
    I just found out I have type 2 diabetes, and I have symptoms 12.06.2026 6m
    What should you do if you've just been diagnosed with Type 2 diabetes and you're already experiencing symptoms?In this episode, endocrinologist Dr. Jonas Leibowitz draws on more than 30 years of clinical experience to explain what happens when Type 2 diabetes presents with symptoms such as excessive thirst, frequent urination, weight loss, blurry vision, and increased hunger. He breaks down the physiology behind these symptoms, helping listeners understand why high blood sugar can lead to dehydration, fatigue, and other warning signs that often bring patients to a doctor's office, urgent care...
  • I have been diagnosed with diabetes, now what?
    I have been diagnosed with diabetes, now what? 29.05.2026 12m
    I Just Found Out I Have Type 2 Diabetes—Now What?Being diagnosed with Type 2 diabetes can feel overwhelming, but understanding what comes next is the first step toward taking control of your health.In this episode of My Diabetes Doc, endocrinologist Dr. Jonas Leibowitz draws on more than 30 years of experience to explain what a new diagnosis of Type 2 diabetes really means and how patients can begin building a successful management plan. From understanding A1C and blood sugar goals to learning about nutrition, exercise, glucose monitoring, and preventive care, Dr. Leibowitz provides a practica...

Popular in

The podcast also appears in the podcast charts of these countries.